Related Experiment Video

Updated: Dec 25, 2025

Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale
10:50

Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale

Published on: March 14, 2019

8.5K

The functions and properties of cullin-5, a potential therapeutic target for cancers

Feng Gao1,2,3, Yimin Fan1,2,3, Bolun Zhou1,2,3

  • 1Cancer Research Institute, Department of Neurosurgery, Xiangya Hospital, Central South University 87 Xiangya Road, Kaifu District, Changsha 410008, China.

American Journal of Translational Research
|March 21, 2020
PubMed

Insights

Cullin-5 (CUL5) is a key protein in cell regulation, often downregulated in cancers. Research reviews its role in normal and cancerous cells, exploring therapeutic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cullin-5 (CUL5) is a scaffold protein within cullin-RING ubiquitin ligase (CRL) complexes.
  • CUL5 facilitates ubiquitination and proteasome degradation of multiple target proteins.
  • CUL5 is crucial for regulating cell growth, proliferation, and other physiological processes.

Purpose of the Study:

  • To review current data on CUL5 expression and function in normal and cancer cells.
  • To explore the mechanisms underlying CUL5's role in cancer.
  • To assess the potential of CUL5 as a therapeutic target for various cancers.

Main Methods:

  • Literature review of existing studies on CUL5.
  • Analysis of data on CUL5 expression in different cell types.
  • Examination of CUL5's involvement in ubiquitination pathways.

Main Results:

  • CUL5 expression is significantly downregulated in numerous cancer types.
  • Altered CUL5 levels impact cancer progression and cellular processes.
  • CUL5's regulatory functions are compromised in the context of cancer.

Conclusions:

  • CUL5 plays a critical role in cellular homeostasis and is frequently dysregulated in cancer.
  • Understanding CUL5's mechanisms in cancer is essential for therapeutic development.
  • CUL5 represents a promising therapeutic target for cancer treatment.
Keywords:
Cullin-5cancermicroRNAsregulationtherapeuticsubiquitin

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.3K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K